The office was dedicated to the long-term safety of vaccines. Experts say plans to track coronavirus vaccines are fragmented and “behind the eight ball.”
Come spring, Americans may have their choice of several so-so coronavirus vaccines — with no way of knowing which one is best.
The company has received a $1.6 billion grant from the government’s Operation Warp Speed to have 100 million doses ready by early 2021.
Operation Warp Speed has moved along at a rapid clip. But some people involved in the approval process fear pressure to deliver an October surprise for President Trump.
The arrangement brings the Trump administration’s investment in coronavirus vaccine projects to more than $8 billion. The head of the federal effort is a former GSK executive.
Billions are being poured into developing a shot, but the rapid timetable and President Trump’s cheerleading are creating a whole new group of vaccine-hesitant patients.
In Boston and in the Netherlands, scientists are racing to build a vaccine against the virus strangling the world.
Novavax just received the Trump administration’s largest vaccine contract. In the Maryland company’s 33-year history, it has never brought a vaccine to market.
Governments have spent trillions in tough times without creating structures that turn short-term fixes into a more inclusive economy.
Aid agencies are scrambling to get oxygen equipment to low-income countries where the coronavirus is rapidly spreading.
The White House is eager to project progress, but the public-private partnership it has created still faces scientific hurdles, internal tensions and questions from Congress.
The pandemic is global, so access to a vaccine should be available to every nation.